Skip to Main Content

WASHINGTON — The White House has been quick to claim credit for numerous drug companies’ decisions to back off planned price hikes for the remainder of 2018.

But such crowing from the Trump administration has not sat well with Democrats, who this week unveiled a pair of bills aimed at lowering prescription drug costs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • This is good commonsense legislation that should pass unanimously. The GOP leaders will NOT allow this Bill to come to the floor for a vote because they are beholden to BIG PHARMA! THINK ABOUT THAT AMERICA!

Comments are closed.